ZP-1 (Guangdong Pharmaceutical University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameZP-1 (Guangdong Pharmaceutical University)
Drug Alias NameEGFR-Kinase-Targeted Cisplatinum (Guandong Pharmaceutical University)Peptide-Cisplatin Conjugate (Guandong Pharmaceutical University)
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Toxin
Mechanisms of ActionDNA intercalatorsEpidermal growth factor receptor erbB1 modulators
TargetsDNAEpidermal growth factor receptor erbB1
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesGuangdong Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangdong Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A